reports
Aclaris Therapeutics to Participate in the H.C. Wainwright Inflammatio...
Aclaris Therapeutics to Participate in the H.C. Wainwright Inflammation & Immunology Virtual Conference WAYNE, Pa., June 26, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that it will provide a corporate presentation during the H.C. Wainwright Inflammation & Immunology Virtual Conference. The presentation will take place on Monday, June 30, 2025 at 11:30 AM EDT. A live and archived webcast of the presentation will be accessible ...
Friedman Industries, Incorporated Announces Cash Dividend
Friedman Industries, Incorporated Announces Cash Dividend LONGVIEW, Texas, June 25, 2025 (GLOBE NEWSWIRE) -- -- The Board of Directors (the “Board”) of Friedman Industries, Incorporated, (NASDAQ/GS: FRD) a Texas-based company engaged in steel processing, pipe manufacturing, and steel and pipe distribution, declared on June 25, 2025, a cash dividend of $0.04 per share on the Common Stock of the Company. The Company will pay the cash dividend on August 8, 2025 to shareholders of record at the close of business on July 18, 2025. This dividend marks the Company’s 214th consecutive quarterly...
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
20-Day MA Supports Holding on SPX, QQQ, IWM The S&P 500 (SPX), Nasdaq 100 (QQQ), and Russell 2000 (IWM) each continue to hold above short-term support at their respective 20-day MAs (currently 5966 on SPX, $526.50 on QQQ, and $208.75 on IWM) -- and have not closed below their 20-day MAs for two months. As long as 20-day MA supports hold, our near-term bullish outlook that we have had since our 4/22/25 Compass remains intact. We will need to see breakdowns below 20-day MA supports in order to ex...
TXRH TEXAS ROADHOUSE INC.
PLAY DAVE & BUSTER'S ENTERTAINMENT INC.
HRL HORMEL FOODS CORPORATION
EAT BRINKER INTERNATIONAL INC.
DIN DINE BRANDS GLOBAL INC.
DAR DARLING INGREDIENTS INC.
CALM CAL-MAINE FOODS INC.
CAKE CHEESECAKE FACTORY INCORPORATED
P5Y BRF SA
BJRI BJ'S RESTAURANTS INC.
SEB MIEN TRUNG POWER INVESTMENT AND DEVELOPMENT
NATH NATHAN'S FAMOUS INC.
BH BIGLARI HOLDINGS B
- Wedbush Research
Aclaris Therapeutics Initiates Phase 1a/1b Program for its Novel Bispe...
Aclaris Therapeutics Initiates Phase 1a/1b Program for its Novel Bispecific Antibody ATI-052 - Potential Best-In-Class Bispecific Antibody ATI-052 Targets Both Thymic Stromal Lymphopoietin (TSLP) and Interleukin-4 Receptor (IL-4R) - WAYNE, Pa., June 23, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that it has initiated a placebo-controlled Phase 1a/1b program for ATI-052, the Company’s potential best-in-class investigational bi...
- David Nierengarten
- Dennis Pak
- Martin Fan
- David Nierengarten
- Dennis Pak
- Dylan Shindler
- Laura Chico
- Martin Fan
- Ritika Das
- Robert Driscoll
- Yun Zhong
- Abe Rimatzki
- Seth Basham
TSLA TESLA INC
PEGA PEGASYSTEMS INC.
NVDA NVIDIA CORPORATION
LGIH LGI HOMES INC.
LEN LENNAR CORPORATION CLASS A
ACRS ACLARIS THERAPEUTICS INC.
BLDR BUILDERS FIRSTSOURCE INC.
EA ELECTRONIC ARTS INC.
PTGX PROTAGONIST THERAPEUTICS
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
LYFT LYFT
PINS PINTEREST INC. CLASS A
UBER UBER TECHNOLOGIES INC.
U UNITY SOFTWARE
UFPI UFP INDUSTRIES INC.
PLTK PLAYTIKA HOLDING
RBLX ROBLOX
APP APPLOVIN CORP
ATXS ASTRIA THERAPEUTICS INC
MLTX MOONLAKE IMMUNOTHERAPEUTICS
SOUN SOUNDHOUND AI INC
APGE APOGEE THERAPEUTICS INC
TLX TELIX PHARMACEUTICALS LIMITED
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
Semiconductors and Technology Leading the Way We remain near-term bullish since our 4/22/25 Compass, and our intermediate-term outlook remains bullish as well (as of our 5/14/25 Compass). We will maintain our bullish view as long as market dynamics remain healthy and the S&P 500 (SPX) is above 5700-5785 (up from 5500). We continue to be buyers in the 5700-5785 range if it gets there, and we would also be buyers at 5804-5854 gap support. We are expecting all-time highs soon on the SPX. Technolo...
LPG DORIAN LPG
G2O GOLAR LNG LIMITED
RIGN TRANSOCEAN LTD.
TRT1 TRANSATLANTIC PETROLEUM LTD.
INSW INTERNATIONAL SEAWAYS INC.
SMH MARKET VECTORS SMEICONDOUCTOR ETF
SDRL SEADRILL LTD.
STNG SCORPIO TANKERS INC.
VAL VALARIS LTD
ALCC ALTC ACQUISITION CORP
SMR NUSCALE POWER CORP
FRO FRONTLINE PLC
NE NOBLE CORP (NEW)
NNE NANO NUCLEAR ENERGY
TNK SEADRILL LTD
CPLPB TEEKAY TANKERS LTD.
TK CARGOPORT LOGISTICS CA PFD B
TEEKAY CORPORATION LTD.
Paycom Software Inc: 1 director
A director at Paycom Software Inc sold 1,500 shares at 249.959USD and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Dave & Buster’s Announces Promotion of Les Lehner to Chief Development...
Dave & Buster’s Announces Promotion of Les Lehner to Chief Development Officer DALLAS, June 13, 2025 (GLOBE NEWSWIRE) -- Dave & Buster's Entertainment, Inc., (NASDAQ: PLAY), ("Dave & Buster's" or "the Company") today announced that it has promoted Les Lehner to the position of Chief Development Officer. Mr. Lehner most recently served as Chief Procurement Officer and Head of Main Event Development. In connection with this promotion, the Company announced that John Mulleady, current Chief Development Officer, will retire effective as of the close of business on October 23, 2025. Effective...
Friedman Industries, Incorporated Announces Fourth Quarter and Fiscal ...
Friedman Industries, Incorporated Announces Fourth Quarter and Fiscal Year 2025 Results LONGVIEW, Texas, June 12, 2025 (GLOBE NEWSWIRE) -- Friedman Industries, Incorporated (NASDAQ/GS: FRD) announced today its results of operations for the quarter and fiscal year ended March 31, 2025. March 31, 2025 Quarter Highlights: Net earnings of $5.3 millionSales of $129.2 millionHighest sales volume in Company history28% increase in sales volume over the preceding third quarter5% increase in sales volume over the prior year fourth quarter Fiscal Year March 31, 2025 Highlights: Net earnings of $...
- Wedbush Research
- David Nierengarten
- Dennis Pak
- Martin Fan
- Yun Zhong
Dave & Buster’s Reports First Quarter 2025 Financial Results
Dave & Buster’s Reports First Quarter 2025 Financial Results DALLAS, June 10, 2025 (GLOBE NEWSWIRE) -- Dave & Buster's Entertainment, Inc., (NASDAQ: PLAY), (“Dave & Buster's” or “the Company”), an owner and operator of entertainment and dining venues, today announced financial results for its first quarter of fiscal 2025 ended May 6, 2025. First Quarter 2025 Financial Summary First quarter revenue of $567.7 million decreased 3.5% from the first quarter of fiscal 2024.Comparable store sales decreased 8.3% compared to the same calendar period in fiscal 2024.Net income totaled $21.7 millio...
MongoDB Inc: 2 directors
Two Directors at MongoDB Inc sold/sold after exercising options 27,005 shares at 234.000USD. The significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over...
- Wedbush Research
- David Nierengarten
- Dennis Pak
- Martin Fan
- Wedbush Research
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.